Immunity to Rhodococcus equi

S. A. Hines, S. T. Kanaly, Barbara A Byrne, G. H. Palmer

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Rhodococcal pneumonia is an important, life threatening disease of foals and immunosuppressed humans. Increased knowledge of the mechanisms of protective immunity are required in order to develop an effective immunoprophylaxis strategy for horses and immunotherapeutic regiments for people. Both humoral and cellular components of the immune system may be involved in immune clearance of R. equi. The susceptibility of foals less than 4-6 months of age is postulated to reflect waning maternal antibody, and passive transfer of hyperimmune plasma can provide protection on endemic farms. However, effective clearance is likely to require appropriate cellular responses, including the secretion of cytokines. In murine models, both CD4 + and CD8 + T lymphocytes can reduce bacterial counts in the lung. CD4 + cells appear to be both required and sufficient, and IFN-gamma is a primary mediator. Clearance appears to be a type 1 immune response while type 2 responses may lead to a failure to clear and lesion development. It remains to be determined how the cellular immunity experiments reported in mice relate to horses and humans. Likewise, the role of specific R. equi antigens in protective immunity has not been determined.

Original languageEnglish (US)
Pages (from-to)177-185
Number of pages9
JournalVeterinary Microbiology
Volume56
Issue number3-4
DOIs
StatePublished - Jun 16 1997
Externally publishedYes

Fingerprint

Rhodococcus equi
foals
Horses
Immunity
immunity
horses
Passive Immunization
maternal immunity
Bacterial Load
Cellular Immunity
lesions (animal)
cell-mediated immunity
plate count
pneumonia
immune system
Immune System
Pneumonia
cytokines
T-lymphocytes
animal models

Keywords

  • Pulmonary immunity
  • Review
  • Rhodococcus equi
  • Th1 immunity

ASJC Scopus subject areas

  • Animal Science and Zoology
  • Microbiology
  • veterinary(all)

Cite this

Hines, S. A., Kanaly, S. T., Byrne, B. A., & Palmer, G. H. (1997). Immunity to Rhodococcus equi. Veterinary Microbiology, 56(3-4), 177-185. https://doi.org/10.1016/S0378-1135(97)00086-2

Immunity to Rhodococcus equi. / Hines, S. A.; Kanaly, S. T.; Byrne, Barbara A; Palmer, G. H.

In: Veterinary Microbiology, Vol. 56, No. 3-4, 16.06.1997, p. 177-185.

Research output: Contribution to journalArticle

Hines, SA, Kanaly, ST, Byrne, BA & Palmer, GH 1997, 'Immunity to Rhodococcus equi', Veterinary Microbiology, vol. 56, no. 3-4, pp. 177-185. https://doi.org/10.1016/S0378-1135(97)00086-2
Hines, S. A. ; Kanaly, S. T. ; Byrne, Barbara A ; Palmer, G. H. / Immunity to Rhodococcus equi. In: Veterinary Microbiology. 1997 ; Vol. 56, No. 3-4. pp. 177-185.
@article{13cc35c606cd468e90adddb7765efb6b,
title = "Immunity to Rhodococcus equi",
abstract = "Rhodococcal pneumonia is an important, life threatening disease of foals and immunosuppressed humans. Increased knowledge of the mechanisms of protective immunity are required in order to develop an effective immunoprophylaxis strategy for horses and immunotherapeutic regiments for people. Both humoral and cellular components of the immune system may be involved in immune clearance of R. equi. The susceptibility of foals less than 4-6 months of age is postulated to reflect waning maternal antibody, and passive transfer of hyperimmune plasma can provide protection on endemic farms. However, effective clearance is likely to require appropriate cellular responses, including the secretion of cytokines. In murine models, both CD4 + and CD8 + T lymphocytes can reduce bacterial counts in the lung. CD4 + cells appear to be both required and sufficient, and IFN-gamma is a primary mediator. Clearance appears to be a type 1 immune response while type 2 responses may lead to a failure to clear and lesion development. It remains to be determined how the cellular immunity experiments reported in mice relate to horses and humans. Likewise, the role of specific R. equi antigens in protective immunity has not been determined.",
keywords = "Pulmonary immunity, Review, Rhodococcus equi, Th1 immunity",
author = "Hines, {S. A.} and Kanaly, {S. T.} and Byrne, {Barbara A} and Palmer, {G. H.}",
year = "1997",
month = "6",
day = "16",
doi = "10.1016/S0378-1135(97)00086-2",
language = "English (US)",
volume = "56",
pages = "177--185",
journal = "Veterinary Microbiology",
issn = "0378-1135",
publisher = "Elsevier",
number = "3-4",

}

TY - JOUR

T1 - Immunity to Rhodococcus equi

AU - Hines, S. A.

AU - Kanaly, S. T.

AU - Byrne, Barbara A

AU - Palmer, G. H.

PY - 1997/6/16

Y1 - 1997/6/16

N2 - Rhodococcal pneumonia is an important, life threatening disease of foals and immunosuppressed humans. Increased knowledge of the mechanisms of protective immunity are required in order to develop an effective immunoprophylaxis strategy for horses and immunotherapeutic regiments for people. Both humoral and cellular components of the immune system may be involved in immune clearance of R. equi. The susceptibility of foals less than 4-6 months of age is postulated to reflect waning maternal antibody, and passive transfer of hyperimmune plasma can provide protection on endemic farms. However, effective clearance is likely to require appropriate cellular responses, including the secretion of cytokines. In murine models, both CD4 + and CD8 + T lymphocytes can reduce bacterial counts in the lung. CD4 + cells appear to be both required and sufficient, and IFN-gamma is a primary mediator. Clearance appears to be a type 1 immune response while type 2 responses may lead to a failure to clear and lesion development. It remains to be determined how the cellular immunity experiments reported in mice relate to horses and humans. Likewise, the role of specific R. equi antigens in protective immunity has not been determined.

AB - Rhodococcal pneumonia is an important, life threatening disease of foals and immunosuppressed humans. Increased knowledge of the mechanisms of protective immunity are required in order to develop an effective immunoprophylaxis strategy for horses and immunotherapeutic regiments for people. Both humoral and cellular components of the immune system may be involved in immune clearance of R. equi. The susceptibility of foals less than 4-6 months of age is postulated to reflect waning maternal antibody, and passive transfer of hyperimmune plasma can provide protection on endemic farms. However, effective clearance is likely to require appropriate cellular responses, including the secretion of cytokines. In murine models, both CD4 + and CD8 + T lymphocytes can reduce bacterial counts in the lung. CD4 + cells appear to be both required and sufficient, and IFN-gamma is a primary mediator. Clearance appears to be a type 1 immune response while type 2 responses may lead to a failure to clear and lesion development. It remains to be determined how the cellular immunity experiments reported in mice relate to horses and humans. Likewise, the role of specific R. equi antigens in protective immunity has not been determined.

KW - Pulmonary immunity

KW - Review

KW - Rhodococcus equi

KW - Th1 immunity

UR - http://www.scopus.com/inward/record.url?scp=0030855399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030855399&partnerID=8YFLogxK

U2 - 10.1016/S0378-1135(97)00086-2

DO - 10.1016/S0378-1135(97)00086-2

M3 - Article

VL - 56

SP - 177

EP - 185

JO - Veterinary Microbiology

JF - Veterinary Microbiology

SN - 0378-1135

IS - 3-4

ER -